Pharma Reviews: Pharmexcil concerned over false media reports to contain Indian exports to global markets

The council said there have been false reports doing rounds in certain international media about Indian pharma companies becoming breeding ...
Read more: Pharmexcil concerned over false media reports to contain Indian exports to global markets

Pharma Reviews: Khandelwal Labs in talks to sell oncology portfolio to Italy's Menarini

Drug maker Khandelwal Laboratories is in advanced talks to sell its ... According to a recent report by PwC, the Indian pharma industry is likely to be ...
Read more: Khandelwal Labs in talks to sell oncology portfolio to Italy's Menarini

Pharma Jobs: SR STATISTICAL PROGRAMMER

Company: My Riad Consulting
Qualification: Any graduate
Experience: 7 to 9
location: Bengaluru / Bangalore
Ref: 19582299
Summary: 7+ Years of Relevant Experience in SR CLINICAL SAS PROGRAMMING in Bangalore.

Read more: SR STATISTICAL PROGRAMMER

Pharma Reviews: Most Indians are still unable to buy critical illness drugs, here's why

Being able to bear the cost of critical illness drugs is still a big issue in India. ... Pharma companies charge high premiums for branded biological ...
Read more: Most Indians are still unable to buy critical illness drugs, here's why

Pharma Reviews: Indian pharma sector to opt for new age digital marketing, here's why

Indian Pharmaceutical companies are now getting rid of the old school marketing techniques and are opting for the new technologies. This new ...
Read more: Indian pharma sector to opt for new age digital marketing, here's why

Pharma Reviews: Critical illness drugs remain unaffordable

The National Pharmaceutical Pricing Authority (NPPA) ceiling price for ... prices", says Indian Pharmaceutical Alliance secretary general D G Shah.
Read more: Critical illness drugs remain unaffordable

Pharma Reviews: Indian pharma sector going digital at a fast pace

NEW DELHI: A digital wave is sweeping across the $17 billion Indian pharmaceutical industry and companies are dumping old ways of marketing for ...
Read more: Indian pharma sector going digital at a fast pace

Pharma Reviews: Domestic pharma firms zoom past MNCs in growth, market share

Domestic pharma companies enjoy a 77 per cent share of the Indian pharma market, and this share has been consistently above 74 per cent in the ...
Read more: Domestic pharma firms zoom past MNCs in growth, market share

Pharma Reviews: Sakthivel Selvaraj: Fine-tuning drug regulation

Sakthivel Selvaraj India currently produces over Rs 200,000 crore worth of medicines and vaccines annually, supplying to the domestic market and to ...
Read more: Sakthivel Selvaraj: Fine-tuning drug regulation

Pharma Reviews: Indian pharma keen to identify and mitigate risks in audit management at its production plants

Indian pharma sector is now keen to identify, assess and mitigate various risks in audit management at plants. In the wake of US regulatory surprise ...
Read more: Indian pharma keen to identify and mitigate risks in audit management at its production plants

Pharma Reviews: Pharma cos alerted on cyber crime

"The scamsters have been able to open bank accounts in Indian companies' name. This opening of fraud accounts with Indian addresses leads to a ...
Read more: Pharma cos alerted on cyber crime

US FDA News: HeartWare Ventricular Assist Device (HVAD) Pumps by HeartWare Inc.: Class I Recall - Loose Connectors May Prevent Alarm from Sounding

Loose power connector may allow moisture to enter the controller causing corrosion, electrical issues, reduced speaker volume and connection failures.
Read more: HeartWare Ventricular Assist Device (HVAD) Pumps by HeartWare Inc.: Class I Recall - Loose Connectors May Prevent Alarm from Sounding

Pharma Reviews: Superbug: Pharmexcil pooh-poohs charges against Indian drug-makers

Pharmaceuticals Export Promotion Council of India (Pharmexcil) has condemned the allegations that some Indian pharma companies are contributing ...
Read more: Superbug: Pharmexcil pooh-poohs charges against Indian drug-makers

Pharma Reviews: ComMin Hits Back on Charges of Superbugs

“In the recent past, there was much of adverse propaganda against Indian companies with the intention of maligning the image of Indian pharma, and ...
Read more: ComMin Hits Back on Charges of Superbugs

US FDA News: FDA approves new device for prevention of recurrent strokes in certain patients

The U.S. Food and Drug Administration today approved the Amplatzer PFO Occluder device. The PFO Occluder reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot that passed through a small hole in the heart, called a patent foramen ovale (PFO), and then traveled to the brain.
Read more: FDA approves new device for prevention of recurrent strokes in certain patients

Pharma Reviews: 'Boycott of Chinese goods will hurt India more'

Reacting to current attempts for boycott of Chinese goods in India, the ... "Our pharma companies, for instance, have been recognised by the United ...
Read more: 'Boycott of Chinese goods will hurt India more'

Pharma Reviews: Boycott of Chinese goods: China warns of impact on India-bound investments

"Moreover, 60-70% of Indian APIs for its pharmaceutical industry are from ... China has played an important role in Indian pharmaceutical industry's ...
Read more: Boycott of Chinese goods: China warns of impact on India-bound investments

Pharma Reviews: China warns of impact on India-bound investments from boycott

"Moreover, 60-70 % of Indian APIs for its pharmaceutical industry are from China. China has played an important role in Indian pharmaceutical ...
Read more: China warns of impact on India-bound investments from boycott

Pharma Reviews: India better placed to reap benefit of biologics patent expiry: say experts

It will help Indian biosimilar industry attract more investment and reap ... on copies of biosimilars has provided Indian pharma tremendous opportunity.
Read more: India better placed to reap benefit of biologics patent expiry: say experts

Pharma Reviews: Biggest losers of our goods' boycott to be Indian traders, consumers: China

It said around 70 percent of Indian APIs (Active Pharmaceutical Ingredients) for its pharmaceutical industry are from China, claiming that Beijing has ...
Read more: Biggest losers of our goods' boycott to be Indian traders, consumers: China

Pharma Reviews: Pharmexcil says lobby at work against Indian pharma

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) on Thursday put its weight behind the companies, blamed by a European ...
Read more: Pharmexcil says lobby at work against Indian pharma

Pharma Reviews: Pharmexcil rebuts superbug charges

​Hyderabad: The Pharmaceutical Export Promotion Council of India (Pharmexcil) on Thursday stoutly refuted allegations that effluents produced by ...
Read more: Pharmexcil rebuts superbug charges

Pharma Reviews: Pharmexcil backs Indian drug makers in study on superbugs by European lobby

Hyderabad: Pharmaceuticals Export Promotion Council of India ... and “backed by vested interests” to malign the Indian pharma industry—the world's ...
Read more: Pharmexcil backs Indian drug makers in study on superbugs by European lobby

Pharma Reviews: Environmental lobby groups blame production methods of drug companies for rise in drug-resistant ...

The Pharmaceuticals Export Council of India (Pharmexcil) set up by the Ministry of Commerce and Industry under foreign trade policy on Thursday ...
Read more: Environmental lobby groups blame production methods of drug companies for rise in drug-resistant ...

Pharma Reviews: China says boycott of its goods will hurt Indian consumers

"Our pharma companies, for instance, have been recognised by the United ... the pace of granting clearances to Indian pharmaceutical companies.
Read more: China says boycott of its goods will hurt Indian consumers

Pharma Reviews: China says boycott of its goods will hurt Indian consumers

China says boycott of its goods will hurt Indian consumers ... "Our pharma companies, for instance, have been recognised by the United States Food ...
Read more: China says boycott of its goods will hurt Indian consumers

Pharma Reviews: Pharmexcil condemns Intl report on Indian Pharma

Condemning the recent International report alleging that Indian Pharmaceutical Industry is responsible for causing ' Drug Resistant Bacteria ...
Read more: Pharmexcil condemns Intl report on Indian Pharma

Pharma Reviews: India drug industry lobby hits back at antibiotic pollution claims

P.V. Appaji, director of the Pharmaceutical Export Promotion Council (Pharmexil), said Indian drug factories' environmental standards were regularly ...
Read more: India drug industry lobby hits back at antibiotic pollution claims

Pharma Reviews: Conspiracy to defame Indian pharma globally is on: Pharmexcil

In the recent past, much of adverse propaganda is taking place against the Indian companies with an intention to malign the image of Indian pharma ...
Read more: Conspiracy to defame Indian pharma globally is on: Pharmexcil

Pharma Reviews: China warns of impact on India-bound investments from boycott

“Moreover, 60-70 per cent of Indian APIs for its pharmaceutical industry are from China. China has played an important role in Indian pharmaceutical ...
Read more: China warns of impact on India-bound investments from boycott

Pharma Reviews: China warns boycott of its goods will hit India-bound investments

“The exports to India accounted for only 2 per cent of China's total exports ... China has played an important role in Indian pharmaceutical industry's ...
Read more: China warns boycott of its goods will hit India-bound investments

Pharma Reviews: China warns of impact on India-bound investments from boycott

"The exports to India accounted for only 2 per cent of China's total exports ... China has played an important role in Indian pharmaceutical industry's ...
Read more: China warns of impact on India-bound investments from boycott

Pharma Reviews: The Embassy further said China-India trade cooperation

"Moreover, 60-70 per cent of Indian APIs for its pharmaceutical industry are from China. China has played an important role in Indian pharmaceutical ...
Read more: The Embassy further said China-India trade cooperation

Pharma Reviews: Goods Boycott Will Hurt Indians More Than Chinese, Says China

“Moreover, 60% to 70% of Indian APIs (Active Pharmaceutical Ingredients) for its pharmaceutical industry are from China. China has played an ...
Read more: Goods Boycott Will Hurt Indians More Than Chinese, Says China

Pharma Reviews: Dun & Bradstreet India launches first edition of India's leading pharma cos

The significance of India's pharmaceuticals sector can be gauged from the fact that in FY16, India's exports of pharmaceutical products stood at USD ...
Read more: Dun & Bradstreet India launches first edition of India's leading pharma cos

Pharma Reviews: Sun Pharma launches blood pressure drugs in US

An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai April 7, 2014.
Read more: Sun Pharma launches blood pressure drugs in US

Pharma Reviews: HUL, Hero Motocorp, Torrent Pharma stocks in focus post Q2 nos

Some of the stocks that should be on your radar are: Indian Hotels Company, Tata Steel, Tata Power Company, Hindustan Unilever, Hero Motocorp, ...
Read more: HUL, Hero Motocorp, Torrent Pharma stocks in focus post Q2 nos

Pharma Reviews: Irish pharma firm Perrigo looks to sell Indian plant to cut debt

Among Indian companies, Torrent Pharmaceuticals Ltd acquired Glochem Industries Ltd's API manufacturing unit at Visakhapatnam in June this year ...
Read more: Irish pharma firm Perrigo looks to sell Indian plant to cut debt

Pharma Reviews: Indian pharma to take on Chinese imports of critical drugs

Speaking about other challenges, he said that the Indian pharma industry is reeling under a massive shortage of skilled manpower. "As an industry ...
Read more: Indian pharma to take on Chinese imports of critical drugs

Pharma Jobs: Need Scientist--Bangalore----([HIDDEN TEXT]) -040-39879815

Company: 2COMS Consulting Private Limited
Qualification: B.E/B.Tech, B.Sc, M.Sc
Experience: 0 to 2
Salary: 4.50 to 5.50
location: Kolkata, Mumbai
Ref: 19409874
Summary: Scientist – Human GeneticsEducation- M Sc in any branch of Life Sciences.

Read more: Need Scientist--Bangalore----([HIDDEN TEXT]) -040-39879815

Pharma Reviews: Pharma: FDA Blues

Indian pharma companies have had to pay a heavy cost for non-compliance with US FDA regulations and post-ban remedial measures using pricey ...
Read more: Pharma: FDA Blues

US FDA News: TAH-t Companion 2 Driver System (C2) and Freedom Driver System by SynCardia Systems: Letter to Health Care Providers - Mortality and Neurological Adverse Event Results

The most recent post-approval study results assessing post-market performance is available.
Read more: TAH-t Companion 2 Driver System (C2) and Freedom Driver System by SynCardia Systems: Letter to Health Care Providers - Mortality and Neurological Adverse Event Results

Pharma Reviews: 'Qualiminds Hopes To Improve The Indian Drug Industry's Image'

K. Anand, CEO and managing director, Qualiminds, tells BW Businessworld that the pharmaceutical industry's attitude to compliance with regulatory ...
Read more: 'Qualiminds Hopes To Improve The Indian Drug Industry's Image'

Pharma Reviews: Pharmexcil seeks mfg cluster to counter Chinese imports

Pharmexcil and Bulk Drug Manufacturers Association of India are in discussion with the Centre on "why can't we see the top 100 products that are ...
Read more: Pharmexcil seeks mfg cluster to counter Chinese imports

Pharma Reviews: Pharma units foresee growth

Banking on patent expiry of several drugs in near future, Indian pharma ... Pharmexcil, the pharma exports body representing the industry, said here ...
Read more: Pharma units foresee growth

Pharma Reviews: PMO push for production of drug APIs in India

TO reduce its dependence on China for active pharmaceutical ingredients (APIs) of drugs, the Prime Minister's Office has instructed the NITI Aayog ...
Read more: PMO push for production of drug APIs in India

Pharma Reviews: Domestic pharma firms zoom past MNCs in growth, market share

Domestic pharma companies enjoy a 77 per cent share of the Indian pharma market (IPM), and this share has been consistently above 74 per cent in ...
Read more: Domestic pharma firms zoom past MNCs in growth, market share

US FDA News: Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence

New Warning and updated Abuse and Dependence sections of labeling, including new safety information from published literature and case reports.
Read more: Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence

Pharma Reviews: Domestic pharma firms zoom past MNCs in growth, market share

The domestic pharma companies enjoy 77% share of the Indian pharma market (IPM), and it has been consistently above 74% for the past four years ...
Read more: Domestic pharma firms zoom past MNCs in growth, market share

Pharma Reviews: Pharmexcil seeks mfg cluster to counter Chinese imports

Most of the companies depend on Chinese imports. Pharmexcil and Bulk Drug Manufacturers Association of India are in discussion with the Centre on ...
Read more: Pharmexcil seeks mfg cluster to counter Chinese imports

Pharma Reviews: Tech-driven pharma sector sees merits & demerits in social media at work

For the India pharma sector, which relies heavily on technology, the use of social media during office hours seems to have both positives and ...
Read more: Tech-driven pharma sector sees merits & demerits in social media at work

Pharma Reviews: Nearly 50% Indian pharma cos under pressure to opt out of US market over DSCSA mandate

Even as the November 2017 deadline for implementation of second phase of US Drug Supply Chain Security Act (DSCSA) is approaching fast, ...
Read more: Nearly 50% Indian pharma cos under pressure to opt out of US market over DSCSA mandate

US FDA News: HeartWare Ventricular Assist Device (HVAD) Pumps by HeartWare Inc. : Class I Recall - Contamination Causing Electrical Issues

Contamination of the driveline may result in fluid or other material entering the pump and causing electrical issues or pump stops that may lead to serious adverse health consequences, including death.
Read more: HeartWare Ventricular Assist Device (HVAD) Pumps by HeartWare Inc. : Class I Recall - Contamination Causing Electrical Issues

Pharma Reviews: SC backs govt on fixing drug prices outside of essential list

SC backs govt on fixing drug prices outside of essential list ... The Indian Pharmaceutical Alliance is a grouping of top Indian drug makers. A July 2014 ...
Read more: SC backs govt on fixing drug prices outside of essential list

Pharma Reviews: Domestic market revives, but US woes to hit pharma firms' earnings

Indian firms have stepped up investments in research and development to enhance their product pipeline, especially in the specialty drugs and ...
Read more: Domestic market revives, but US woes to hit pharma firms' earnings

Pharma Reviews: Domestic Market Recovery, Favourable Currencies To Support Pharma Firms In Second Quarter

Recovery in domestic sales and a favorable trend of non-U.S. currencies are seen boosting earnings of Indian pharmaceutical companies in the April ...
Read more: Domestic Market Recovery, Favourable Currencies To Support Pharma Firms In Second Quarter

Pharma Reviews: Pharma companies increase investments for global biosimilar push

"We see opportunities for Indian drug companies in biosimilars in local and emerging markets. We expect them to partner with other companies for ...
Read more: Pharma companies increase investments for global biosimilar push

Pharma Reviews: Diwali 2016: 10 stocks to buy this Deepawali in Muhurat Trading

1) State Bank of India: The public sector bank is the largest lender in the ... track records with the US FDA cGMP among Indian pharma companies.
Read more: Diwali 2016: 10 stocks to buy this Deepawali in Muhurat Trading

Pharma Reviews: Failure to comply with norms in pharma sector a big risk: Experts

AURANGABAD: Members of the Indian Pharmaceutical Association (IPA) and Food and Drugs Administration (FDA) officials called for proper ...
Read more: Failure to comply with norms in pharma sector a big risk: Experts

Pharma Reviews: Drug Price Control Order continues to drag growth of pharma industry

According to latest estimates from ICRA approximately 17 per cent of the Indian Pharma Market (IPM) is under DPCO. The DPCO drugs segment has ...
Read more: Drug Price Control Order continues to drag growth of pharma industry

Pharma Reviews: Sun Pharma completes divestment of 7 brands to RPG

NEW DELHI: Sun Pharmaceutical Industries on Friday completed the divestment of its seven prescription brands in India to RPG Life Sciences.
Read more: Sun Pharma completes divestment of 7 brands to RPG

Pharma Reviews: Swadeshi Jagran Manch excludes capital goods from anti-China drive

“For example, nearly 65% of the chemicals used in the pharmaceutical industry are imported from China. If there is a boycott, the Indian pharma sector ...
Read more: Swadeshi Jagran Manch excludes capital goods from anti-China drive

Pharma Reviews: 3 Indian Pharma cos breeding drug-resistant Bacteria: Report

MUMBAI: Three Indian drug companies have been accused of causing drug-resistance bacteria due to their polluting manufacturing practices, ...
Read more: 3 Indian Pharma cos breeding drug-resistant Bacteria: Report

US FDA News: Willy Rusch Tracheostomy Tube Set by TeleFlex Medical: Class I Recall - Possible Disconnection During Patient Use

Connector detachment during use can deprive patient of adequate ventilation and require immediate medical intervention.
Read more: Willy Rusch Tracheostomy Tube Set by TeleFlex Medical: Class I Recall - Possible Disconnection During Patient Use

US FDA News: Radiation Therapy Devices by Multidata Systems International: Discontinue Use – Concerns about Risks to Patients

The FDA is concerned that health care providers may be unaware of the risks associated with these devices.
Read more: Radiation Therapy Devices by Multidata Systems International: Discontinue Use – Concerns about Risks to Patients

US FDA News: FDA grants accelerated approval to new treatment for advanced soft tissue sarcoma

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues. Lartruvo is approved for use with the FDA-approved chemotherapy drug doxorubicin for the treatment of patients with STS who cannot be cured with radiation or surgery and who have a type of STS for which an anthracycline (chemotherapy) is an appropriate treatment.
Read more: FDA grants accelerated approval to new treatment for advanced soft tissue sarcoma

Pharma Reviews: Sun Pharma, ICGEB tie up to develop dengue vaccine

NEW DELHI: Indian pharmaceutical giant Sun Pharma has partnered with International Centre for Genetic Engineering and Biotechnology (ICGEB) to ...
Read more: Sun Pharma, ICGEB tie up to develop dengue vaccine

Pharma Reviews: India's Sun Pharma joins hands with ICGEB to develop dengue vaccine

New Delhi: Indian drug major Sun Pharmaceutical Industries on Wednesday announced a new exclusive collaboration with the International Centre ...
Read more: India's Sun Pharma joins hands with ICGEB to develop dengue vaccine

Pharma Reviews: R&D SPENDING BY PHARMA COS

A Pharmabiz study of R&D spending by 25 research based Indian pharmaceutical companies reveals that their research expenditure during 2015-16 ...
Read more: R&D SPENDING BY PHARMA COS

US FDA News: Medtronic Neurovascular Products: Recall - Potential Separation and Detachment of Polytetrafluoroethylene (PTFE) Coating

PTFE in the blood stream, based on the size and quantity, could lead to a thromboembolic event.
Read more: Medtronic Neurovascular Products: Recall - Potential Separation and Detachment of Polytetrafluoroethylene (PTFE) Coating

Pharma Reviews: Three pharma companies to focus on

Indian pharma companies have seen a topsy-turvy run with fortunes for more than a year now. Oflate too, for instance, in the domestic arena, after a ...
Read more: Three pharma companies to focus on

Pharma Reviews: Big Pharma's India shadow

That's sadly not even an option in India where the nexus between pharma companies and hospitals is pushing up treatment costs while exposing ...
Read more: Big Pharma's India shadow

Pharma Reviews: Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets

Marksans Pharma, headquartered at Mumbai, India, was founded in 2001 and is a global pharmaceutical company engaged in R&D and offer ...
Read more: Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets

US FDA News: FDA awards 21 grants to stimulate product development for rare diseases

The U.S. Food and Drug Administration today announced that it has awarded 21 new clinical trial research grants totaling more than $23 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry with research spanning domestic and international clinical sites.
Read more: FDA awards 21 grants to stimulate product development for rare diseases

Pharma Reviews: India overdependent on China for medicines – study

pharma India may have emerged as a key supplier of generic and affordable medicine for the world market, but it has an “overwhelming dependence” ...
Read more: India overdependent on China for medicines – study

Pharma Reviews: Citi India sees Sensex at 30000 mark by March 2017

“There have been multiple issues including USFDA concerns and generic pricing in the US, but we feel Indian pharma companies have the right ...
Read more: Citi India sees Sensex at 30000 mark by March 2017

Pharma Reviews: Domestic growth seen lifting Sep quarter earnings at pharma firms

“The underlying growth continues to remain strong in Indian pharma industry. While the July-September quarter will have a positive impact of ...
Read more: Domestic growth seen lifting Sep quarter earnings at pharma firms

Pharma Reviews: Schneider Electric to make India's pharma plants 'future ready'

The Indian pharmaceutical market is the third largest in the world in terms of value and is expected to reach US $ 55 billion by 2020. However, the ...
Read more: Schneider Electric to make India's pharma plants 'future ready'

Pharma Reviews: Cipla signs deal to set up first biosimilars unit in South Africa

Indian pharmaceutical major Cipla has signed a memorandum of agreement for South Africa's first biosimilars manufacturing facility to be set up at a ...
Read more: Cipla signs deal to set up first biosimilars unit in South Africa

Pharma Reviews: India-US trade relationship to grow: Froman

WASHINGTON: Describing the reforms undertaken by the Indian ... "We continue to work in the pharmaceutical area, and we very much believe that ...
Read more: India-US trade relationship to grow: Froman

Pharma Reviews: Pharma cos may report subdued performance in Q2 FY17: Report

Pharma companies are likely to witness strong recovery in domestic ... The Indian pharma market has reported strong growth of 15 per cent and 18 per ...
Read more: Pharma cos may report subdued performance in Q2 FY17: Report

Pharma Reviews: India-US trade relationship to grow: Michael Froman

One of the key architect of India-US trade relationship in the Obama ... “We continue to work in the pharmaceutical area, and we very much believe that ...
Read more: India-US trade relationship to grow: Michael Froman

Pharma Reviews: Indian government rules out blanket ban on Chinese goods. Know why

"Our pharma companies, for instance, have been recognised by the USFDA (Food and Drug Administration), the European Union. Why is it then that ...
Read more: Indian government rules out blanket ban on Chinese goods. Know why

Pharma Reviews: India To Buy Gamechanger S-400 Air Defence System From Russia

India and Russia have been in talks for over a year for the purchase of at .... The policy disallows non-compete clauses in pharmaceutical deals and ...
Read more: India To Buy Gamechanger S-400 Air Defence System From Russia

Pharma Reviews: Russia Plans $1 Billion India Joint Fund; To Invest $500 Million In NIIF

It will invest into the infrastructure sector in commercially viable projects, ..... have much more focused operations than Indian pharma companies do.
Read more: Russia Plans $1 Billion India Joint Fund; To Invest $500 Million In NIIF

Pharma Reviews: Spectrum Win Credit Negative For Telecom Players: Moody's

Vodafone India took home Rs 20,280 crore worth of spectrum. .... parts of an Indian pharmaceutical company's businesses, to invest in that company.
Read more: Spectrum Win Credit Negative For Telecom Players: Moody's

Pharma Reviews: BSE Sells 4.15% Stake In Central Depository Services

Apart from BSE, other shareholders in CDSL are Bank of India, Bank of .... The policy disallows non-compete clauses in pharmaceutical deals and ...
Read more: BSE Sells 4.15% Stake In Central Depository Services

Pharma Reviews: Sensex At 30: The Journey To Rs 1 Lakh Crore Market Capitalisation

The Sensex was first compiled in 1986 and over the years, the market .... an Indian pharmaceutical company's businesses, to invest in that company.
Read more: Sensex At 30: The Journey To Rs 1 Lakh Crore Market Capitalisation

Pharma Reviews: Urjit Patel Significantly More Dovish Than Rajan: CLSA's Chris Wood

Urjit Patel, who took over as the 24th governor of the Reserve Bank of India in September, .... It happens because a lot of these overseas corporations actually have much more focused operations than Indian pharma companies do.
Read more: Urjit Patel Significantly More Dovish Than Rajan: CLSA's Chris Wood

Pharma Reviews: Sensex, Nifty Hold Slight Gains Despite Infosys Letdown As Energy, Cap Goods Stocks Rally

Indian shares climbed marginal higher but closed the week lower after ..... The policy disallows non-compete clauses in pharmaceutical deals and ...
Read more: Sensex, Nifty Hold Slight Gains Despite Infosys Letdown As Energy, Cap Goods Stocks Rally

Pharma Reviews: Are Conditionalities Choking India's FDI Policy?

It happens because a lot of these overseas corporations actually have much more focused operations than Indian pharma companies do. Frequently ...
Read more: Are Conditionalities Choking India's FDI Policy?

Pharma Reviews: India-US trade relationship to grow: Michael Froman

"We continue to work in the pharmaceutical area, and we very much believe that ... The US Food and Drug Administration (FDA) has a very high safety ...
Read more: India-US trade relationship to grow: Michael Froman

US FDA News: Skintact DF29N Multi-function Defibrillation Electrodes by Leonhard Lang: Class I Recall - Connector Compatibility Issue

User may not be able to connect electrodes to Welch Allyn AED model 10 defibrillator, which may result in a delay in delivering the electrical therapy.
Read more: Skintact DF29N Multi-function Defibrillation Electrodes by Leonhard Lang: Class I Recall - Connector Compatibility Issue

Pharma Reviews: Patent And Pharma Swags - Lawsuits On Patent Infringements In India And Pharma Patents

The Indian courts follow the tradition of civil suits in case of patent ... The issue was well known and curious for the Pharma industry however the ...
Read more: Patent And Pharma Swags - Lawsuits On Patent Infringements In India And Pharma Patents

Pharma Reviews: Dilip Shanghvi, the man behind India's best stock, faces his biggest test

One executive, Srinivas Lanka, recalls the founder of Sun Pharmaceutical ... Shanghvi's largest ever deal, the purchase of Indian rival Ranbaxy ...
Read more: Dilip Shanghvi, the man behind India's best stock, faces his biggest test

Pharma Reviews: China assures wider market access for Indian products

New Delhi, Oct 13 (PTI) China today assured India that it will act on the ... of Indian rice besides a Green Channel for import of Indian pharmaceutical ...
Read more: China assures wider market access for Indian products

Pharma Reviews: Exito Media Concepts announces fifth edition of Pharma Innovation and Technology Summit

New Delhi [India], Oct 13 : With a CAGR of 14 percent, Indian Pharmaceutical Industry will reach an annual turnover of USD 47.06 Billion by 2018.
Read more: Exito Media Concepts announces fifth edition of Pharma Innovation and Technology Summit

Pharma Reviews: Pharmacy Training Institute urges Karnataka govt to give it Finishing School status

So far the industry has picked up every candidate trained by us which ... “The US $22 billion Indian pharma's top 250 companies face an annual ...
Read more: Pharmacy Training Institute urges Karnataka govt to give it Finishing School status

Pharma Reviews: China assures wider market share for Indian goods

The Chinese vice-minister drew attention on China recently quickening the pace of granting clearances to Indian pharma companies for import of ...
Read more: China assures wider market share for Indian goods

US FDA News: Stӧckert 3T Heater-Cooler System by LivaNova PLC (formerly Sorin Group Deutschland GmbH): UPDATED Safety Communication - Reports of Mycobacterium Chimaera Infections

New information about M. chimaera infections, and updated recommendations to help prevent the spread of infection.
Read more: Stӧckert 3T Heater-Cooler System by LivaNova PLC (formerly Sorin Group Deutschland GmbH): UPDATED Safety Communication - Reports of Mycobacterium Chimaera Infections

Pharma Reviews: Delhi to Beijing: give Indian goods greater market access

Raising concerns about its gaping trade deficit with China, India has asked the country for faster clearance of its rice and pharmaceutical exports, grant ...
Read more: Delhi to Beijing: give Indian goods greater market access

Pharma Jobs: Medical Representative

Company: Genetics Call net
Experience: 1 to 4
location: Mumbai, Mumbai City, Navi Mumbai, Thane
Ref: 19496258
Summary: Openings available for the post of Medical Representative with a leading company.

Read more: Medical Representative

Pharma Reviews: China assures wider market access for Indian products

Chinese minister informed Nirmala Sitharaman that recently China has quickened the pace of granting clearances to Indian pharma companies for ...
Read more: China assures wider market access for Indian products

Pharma Reviews: Curofy Hires Jo Peddhinti from Eli Lily to Disrupt Pharma Marketing Industry

Previously, Jo was at Eli Lilly in India, where she was hired by the affiliate to design a digital transformation plan that would allow Lilly to rapidly ...
Read more: Curofy Hires Jo Peddhinti from Eli Lily to Disrupt Pharma Marketing Industry

Pharma Reviews: India urges China to ensure greater market accesss at bi-lateral ministerial meeting

India's Commerce Minister requested for expeditious clearances for import of Indian rice and a 'Green Channel' for import of Indian pharmaceutical ...
Read more: India urges China to ensure greater market accesss at bi-lateral ministerial meeting

Pharma Reviews: China assures wider market access to India for sustainable trade relationship

Sitharaman requested expeditious clearances for import of Indian rice besides a 'Green Channel' for import of Indian pharmaceutical products to ...
Read more: China assures wider market access to India for sustainable trade relationship

Pharma Reviews: Exito Media Concepts announces fifth edition of Pharma Innovation and Technology Summit

With a CAGR of 14 percent, Indian Pharmaceutical Industry will reach an ... An industry predominantly focused on Generics is soon set to diversify its ...
Read more: Exito Media Concepts announces fifth edition of Pharma Innovation and Technology Summit

Pharma Reviews: China assures wider market access for Indian products

China today assured India that it will act on the concerns expressed by ... clearances to Indian pharma companies for import of the pharma products, ...
Read more: China assures wider market access for Indian products

Pharma Reviews: Exito Media Concepts announces fifth edition of Pharma Innovation and Technology Summit

New Delhi [India], Oct 13 (ANI-BusinessWireIndia): With a CAGR of 14 percent, Indian Pharmaceutical Industry will reach an annual turnover of USD ...
Read more: Exito Media Concepts announces fifth edition of Pharma Innovation and Technology Summit

Pharma Reviews: With Sun Pharma set for its worst decline, Dilip Shanghvi faces his greatest test

That kind of relentless drive has helped make Sun India's biggest ... Early on, the company differentiated itself from the crowd of Indian makers of ...
Read more: With Sun Pharma set for its worst decline, Dilip Shanghvi faces his greatest test

Pharma Reviews: Exito Media Concepts Pvt. Ltd. Announces the 5th Edition of Pharma Innovation and Technology ...

With a CAGR of 14%, Indian Pharmaceutical Industry will reach an annual turnover of US $ 47.06 Billion by 2018. An industry predominantly focused ...
Read more: Exito Media Concepts Pvt. Ltd. Announces the 5th Edition of Pharma Innovation and Technology ...

Pharma Reviews: Biosimilars to boost growth of pharma sector in next 15 years: Assocham study

With the government's new initiative of enabling ease of doing business in the country, the Indian pharma cos are expected to reap good benefits from ...
Read more: Biosimilars to boost growth of pharma sector in next 15 years: Assocham study

Pharma Reviews: M&A Artist Behind India's Best Stock Now Faces His Greatest Test

One executive, Srinivas Lanka, recalls the founder of Sun Pharmaceuticals Industries Ltd. calling more than 100 times over three years with a job offer ...
Read more: M&A Artist Behind India's Best Stock Now Faces His Greatest Test

Pharma Reviews: IPA Bengal branch holds workshop on 'Ensuring Data Integrity'

The Bengal branch of the Indian Pharmaceutical Association conducted a national level workshop on the subject, “Ensuring Data Integrity, Need of the ...
Read more: IPA Bengal branch holds workshop on 'Ensuring Data Integrity'

US FDA News: Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) by St. Jude Medical: FDA Safety Communication - Batteries May Fail Earlier Than Expected

In some cases full battery drainage can occur within a day to a few weeks after patient receives ERI alert. If battery runs out, ICD or CRT-D will be unable to deliver life-saving pacing or shocks, which could lead to patient death.
Read more: Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) by St. Jude Medical: FDA Safety Communication - Batteries May Fail Earlier Than Expected

Pharma Reviews: Pharma salesman's company eyes Rs 10k-crore tag in IPO

Mumbai: Indian pharma's first sales professional-turned-entrepreneur, the 41-year-old Amit Bakshi, has hired bankers for a Rs 2,000-crore ...
Read more: Pharma salesman's company eyes Rs 10k-crore tag in IPO

Pharma Reviews: "Quality assurance departments are often given a low priority in the pharma industry"

Leading global consultancy firms like Lachman Consultants, Parexel and Quintiles (now QuintilesIMS), have been in demand in India with ...
Read more: "Quality assurance departments are often given a low priority in the pharma industry"

Pharma Reviews: Indian Pharma market clocks growth of 12.6% in September 2016

According to AIOCD Pharmasofttech AWACS Pvt Ltd the Indian Pharmaceutical Market (IPM) clocked Rs.9,792 crore in September, 2016 and ...
Read more: Indian Pharma market clocks growth of 12.6% in September 2016

Pharma Reviews: R&D spend by 25 Indian pharma cos jumps by 24% in 2015-16, Sun remains top

Investments in Research & Development (R&D) by Indian pharma companies have assisted well to establish strong presence in the highly regulated ...
Read more: R&D spend by 25 Indian pharma cos jumps by 24% in 2015-16, Sun remains top

Pharma Reviews: Pharma salesman's co eyes Rs 10k-cr tag in IPO

Mumbai: Indian pharma's first sales professional-turned-entrepreneur, the ... The company's 25 brands account for 92% of the annual turnover, ...
Read more: Pharma salesman's co eyes Rs 10k-cr tag in IPO

Pharma Reviews: Geistlich Pharma enters Indian market

Swiss medical products firm Geistlich Pharma AG announced the commencement of Indian operations with establishment of its 10th global affiliate, ...
Read more: Geistlich Pharma enters Indian market

Pharma Reviews: Indian drug regulator may scrap licence renewal; move may affect quality of medicines

The Indian Pharmaceutical Alliance, Indian Drug Manufacturers' Association and the Organisation of Pharmaceutical Producers of India did not ...
Read more: Indian drug regulator may scrap licence renewal; move may affect quality of medicines

Pharma Reviews: Indian pharma to become a $55 billion market by 2020: IBEF

In recent times, the pharmaceutical sector had taken a beating over the stricter regulatory actions from the United States Food & Drug Association ...
Read more: Indian pharma to become a $55 billion market by 2020: IBEF

Pharma Reviews: Sathguru in Association With Assocham Releases a White Paper on Biosimilars

"Biosimilars presents a $240 Billion global opportunity for Indian Pharmaceuticals Industry while domestic market is expected to cross $40 Billion by ...
Read more: Sathguru in Association With Assocham Releases a White Paper on Biosimilars

Pharma Reviews: (REOPENS DCM18)

India?s strength in pharma sector and the decision of Japan towards ... an opportunity for the internationally acclaimed generic drug industry of India, ...
Read more: (REOPENS DCM18)

Pharma Reviews: Intas Pharma In No Hurry To List, Says MD Binish Chudgar

Intas Pharmaceuticals Ltd.'s acquisition of Actavis U.K. Ltd. and Actavis ... It figures among the fastest growing Indian pharmaceutical majors and ...
Read more: Intas Pharma In No Hurry To List, Says MD Binish Chudgar

Pharma Reviews: Live: Sensex, Nifty Swing As Telecom Falters; Endurance Tech IPO Fully Subscribed

Indian shares fluctuated between gains and losses as investors chose to ..... It figures among the fastest growing Indian pharmaceutical majors and ...
Read more: Live: Sensex, Nifty Swing As Telecom Falters; Endurance Tech IPO Fully Subscribed

Pharma Reviews: Indian pharma faces dearth of talent as international markets woo qualified personnel

Indian pharma and healthcare industry continues to face dearth of talent as one of the biggest challenges. The sector is facing the paucity of qualified ...
Read more: Indian pharma faces dearth of talent as international markets woo qualified personnel

Pharma Reviews: Indian biosimilars market may reach $40 bn by 2030: Report

HYDERABAD: Biosimilars presents a $240 billion global opportunity for Indian pharmaceuticals industry, while the domestic market is expected to ...
Read more: Indian biosimilars market may reach $40 bn by 2030: Report

Pharma Reviews: India seeks greater pharma market access in Japan

Seeking greater market access for the Indian pharmaceuticals sector in the Japanese market, Commerce Minister Nirmala Sitharaman on Thursday ...
Read more: India seeks greater pharma market access in Japan

Pharma Reviews: Intas emerges as the dark horse of Indian pharma

This is the second largest acquisition by an Indian pharma company abroad after Lupin's Rs 5,600 crore acquisition of Gavis last year in the US.
Read more: Intas emerges as the dark horse of Indian pharma

Pharma Reviews: Top 3 business stories of Oct 6: Indian pharmaceuticals firm Intas Pharmaceuticals to acquire ...

1. Indian pharmaceuticals firm Intas Pharmaceuticals to acquire Actavis Generics's UK assets for around Rs 5,100 crores. Ahmedabad-based Intas ...
Read more: Top 3 business stories of Oct 6: Indian pharmaceuticals firm Intas Pharmaceuticals to acquire ...

Pharma Reviews: Steps have been taken to sort out the implementation issues related to CEPA: Nirmala Sitharaman

Smt. Sitharaman said the Japanese pharmaceutical market offers a huge untapped potential for Indian pharma industry. India's strength in Pharma ...
Read more: Steps have been taken to sort out the implementation issues related to CEPA: Nirmala Sitharaman

Pharma Reviews: Utilise CEPA more to boost export to Japan, government tells companies

Indian companies should utilise CEPA (Comprehensive Economic ... “The share of Indian companies in Japanese drug market continues to be low ...
Read more: Utilise CEPA more to boost export to Japan, government tells companies

Pharma Reviews: Intas buys UK and Ireland assets of Teva for $769 million

This is the second largest overseas deal in the Indian pharmaceutical industry after the acquisition of the US based GAVIS Pharmaceuticals LLC and ...
Read more: Intas buys UK and Ireland assets of Teva for $769 million

Pharma Reviews: Biosimilars presents USD 240 billion opportunity for Indian Pharmaceuticals Industry: Assocham ...

"Biosimilars presents a USD 240 billion global opportunity for Indian Pharmaceuticals Industry while domestic market is expected to cross USD 40 ...
Read more: Biosimilars presents USD 240 billion opportunity for Indian Pharmaceuticals Industry: Assocham ...

Pharma Reviews: Utilise Economic Partnership Agreement more to boost export to Japan, Govt tells companies

Minister of Commerce and Industry, Nirmala Sitharaman, said Indian ... “The share of Indian companies in Japanese drug market continues to be low ...
Read more: Utilise Economic Partnership Agreement more to boost export to Japan, Govt tells companies

Pharma Reviews: Intas Pharmaceuticals Acquires the Generics Business of Actavis in the UK and Ireland

Intas is among the top 10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in ...
Read more: Intas Pharmaceuticals Acquires the Generics Business of Actavis in the UK and Ireland

Pharma Reviews: Indian pharma companies ranked 19 on 28 in competitiveness index

Indian pharmaceutical companies have ranked at the rear end in the recently conducted 2016 Biopharmaceutical Competitiveness & Investment (BCI) ...
Read more: Indian pharma companies ranked 19 on 28 in competitiveness index

Pharma Reviews: Indian pharmaceuticals firm Intas Pharmaceuticals to acquire Actavis Generics's UK assets for ...

Ahmedabad-based Intas Pharmaceuticals will acquire assets and operations of Actavis Generics in the UK and Ireland from Teva Pharmaceuticals for ...
Read more: Indian pharmaceuticals firm Intas Pharmaceuticals to acquire Actavis Generics's UK assets for ...

Pharma Reviews: Intas buys Actavis assets in UK, Ireland for Rs 5100cr

Mumbai: In the the biggest buyout by an Indian pharma company in Europe, Ahmedabad-based Intas, the largest privately held drug maker in the ...
Read more: Intas buys Actavis assets in UK, Ireland for Rs 5100cr

Pharma Reviews: Temasek- backed Intas to buy Teva's operations under Actavis in UK & Ireland for $769 mn

This marks the second biggest overseas acquisition by an Indian pharma company ever. It comes just a year after Lupin Ltd, India's third-largest ...
Read more: Temasek- backed Intas to buy Teva's operations under Actavis in UK & Ireland for $769 mn

Pharma Reviews: India's pharma competitiveness rank drops

The ranking is part of the third edition of the Biopharmaceutical Competitiveness Survey commissioned by the Pharmaceutical Research and ...
Read more: India's pharma competitiveness rank drops

US FDA News: I.V. Flush Syringes by Nurse Assist: Recall - Potential Link to Burkholderia Cepacia Bloodstream Infections

The effects of Burkholderia cepacia on people vary widely, ranging from no symptoms at all to serious respiratory infections, especially in patients with cystic fibrosis.
Read more: I.V. Flush Syringes by Nurse Assist: Recall - Potential Link to Burkholderia Cepacia Bloodstream Infections

US FDA News: Twin-Pass Dual Access Catheters by Vascular Solutions: Recall - Potential for Excess Manufacturing Material At The Tip

Excess material may separate from the catheter during use and pose a potential risk of embolism, which could result in serious injury or death.
Read more: Twin-Pass Dual Access Catheters by Vascular Solutions: Recall - Potential for Excess Manufacturing Material At The Tip

Pharma Reviews: Intas Pharma to acquire Teva's UK, Ireland generics businesses

Intas' acquisition of Teva's UK assets puts it in the big league of large overseas acquisitions by Indian pharma firms. It is also the biggest outbound ...
Read more: Intas Pharma to acquire Teva's UK, Ireland generics businesses

Pharma Reviews: Pharma Marketing Summit 2016 to be held in Mumbai from October 13-14

The pharma industry globally is one of the fastest growing industries, accounting for a total revenue of $3 trillion. The revenue of the Indian pharma ...
Read more: Pharma Marketing Summit 2016 to be held in Mumbai from October 13-14

Pharma Reviews: The Medicine Men

The Indian pharmaceutical industry has spawned many fascinating stories of entrepreneurs, who started out with limited or no resources but went on ...
Read more: The Medicine Men

Pharma Reviews: Fixing the Ranbaxy Problem

BT has pieced together the story of biggest integration in Indian pharma industry through a combination of e-mail responses from the company, ...
Read more: Fixing the Ranbaxy Problem

Pharma Reviews: InvAscent in talks to exit Neuland Group

Mumbai: InvAscent, a pharma and healthcare-focused private equity firm, is in ... in the Indian pharmaceutical, healthcare and medtech industries.
Read more: InvAscent in talks to exit Neuland Group

US FDA News: Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating

FDA requiring a Boxed Warning about the risk of HBV reactivation to be added to drug labels, directing health care professionals to screen and monitor for HBV in all patients receiving DAA treatment.
Read more: Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating

Pharma Reviews: Mitsubishi UFJ backs Aurobindo and Intas for Teva bid

Indian pharma giants are competing with global pharma giants Mylan and Novartis besides ... For Intas Pharmaceuticals, Europe is a key market.
Read more: Mitsubishi UFJ backs Aurobindo and Intas for Teva bid

Pharma Reviews: Drug crisis in store if Sino-Indian ties worsen

Amid signs of China siding with Pakistan, authorities are evaluating options to ensure India's pharma industry, heavily dependent on raw material from ...
Read more: Drug crisis in store if Sino-Indian ties worsen

Pharma Reviews: Drug crisis in store if Sino-Indian ties worsen

Amid signs of China siding with Pakistan, authorities are evaluating options to ensure India's pharma industry , heavily dependent on raw material ...
Read more: Drug crisis in store if Sino-Indian ties worsen

Pharma Reviews: Sun Pharmaceuticals Industries Limited - Press Release

Sun Pharmaceuticals Industries Limited has informed the Exchange ... Actionable & Award-Winning Research on 500 Listed Indian Companies.
Read more: Sun Pharmaceuticals Industries Limited - Press Release

US FDA News: 50mm 0.2 Micron Filters by Baxter: Recall - Potential for Missing Filter Support Membrane, Particulate Matter

Bacteria and/or particulate matter present in an unsterile solution could pass through to a compounded prepared solution, which could lead to adverse health consequences.
Read more: 50mm 0.2 Micron Filters by Baxter: Recall - Potential for Missing Filter Support Membrane, Particulate Matter